Basic Information
| RNALocate ID: | RLID:11000958 |
| RNA Symbol: | hsa-miR-93-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-93-5p |
| RNA ID: | miRBase:MIMAT0000093 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 22211110 |
| Tissue/Cell Line: | Breast milk |
| Method: | Next-generation RNA sequencing |
|
The expression profile of selected miRNAs in breast milk exosomes. Originally published in Int J Biol Sci. Zhou Q, et al, 2012. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
| Description: | Distribution and characterization of miRNAs in breast milk exosomes. (A) Distribution of pre-miRNAs. Out of 1,424 pre-miRNAs deposited in miRBase 17.0 (blue circle), 87 (6.11%) pre-miRNAs have been designated as immune-related pre-miRNAs based on annotation in the Pathway Central database (SABiosciences, MD, USA). Immune-related pre-miRNAs (59 of 452, 13.05%) are enriched in breast milk exosomes (red circle). χ2 test: Number of immune-related miRNAs and others detected in breast milk exosomes compared with the total entries in miRBase 17.0. (B) Top ten most highly expressed unique miRNAs. Plot of the unique miRNAs (starting from the miRNA with the highest counts, x-axis) versus their cumulative % of the total counts from 602 unique miRNAs detected in breast milk exosomes for each small RNA library. Values are means ± s.d. The dashed horizontal line at 62.3% represents the level of the top ten unique miRNAs and the % of individual miRNAs is marked by the gray line. (C-E) The expression profile of selected miRNAs in breast milk exosomes. (C) 59 immune-related pre-miRNAs; (D) miR-17-92 cluster and paralogous clusters, and (E) ten well-characterized tissue-specific pre-miRNAs. Data are collected from Figure 2. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001407 | Cytoplasm | Neural progenitor cells | 21363885 |
| RLID:01001408 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001409 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001410 | Mitochondrion | Myotube | 27396686 |
| RLID:01001411 | Mitochondrion | Skeletal muscle cells | 27563705 |
| RLID:01001412 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001413 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001414 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001415 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001416 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11000952 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11000953 | Exosome | Serum | 29143228 |
| RLID:11000954 | Exosome | Plasma | 30154547 |
| RLID:11000955 | Exosome | Glioblastoma cells | 19011622 |
| RLID:11000956 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11000957 | Exosome | Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000959 | Exosome | Brain tissue | 23382797 |
| RLID:11000960 | Exosome | Plasma | 23663360 |
| RLID:11000961 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000962 | Exosome | Breast cancer cell lines (MCF-7|MDA-MB-231) | 24468161 |
| RLID:11000963 | Exosome | Serum | 25349172 |
| RLID:11000964 | Extracellular Vesicle | Plasma | 28588009 |
| RLID:11000965 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11000966 | Microvesicle | Glioblastoma cells | 19011622 |
| RLID:11000967 | Microvesicle | Plasma | 23077538 |
| RLID:11000968 | Microvesicle | Seminal plasma | 23539611 |
| RLID:11000969 | Microvesicle | Follicular fluid | 23666971 |
| RLID-D:11000028 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Lymphoma tissue|Mast cells|Seminal fluid|Tongue tissue | |
| RLID-D:11000292 | Microvesicle | Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-93-5p | Splenic marginal zone lymphoma | MNDR-E-MI-71712 |
| MNDR | hsa-miR-93-5p | Multiple sclerosis chronic progressive | MNDR-E-MI-71713 |
| MNDR | hsa-miR-93-5p | Oral squamous cell carcinoma | MNDR-E-MI-71714 |
| MNDR | hsa-miR-93-5p | Large cell neuroendocrine cancer | MNDR-E-MI-71715 |
| MNDR | hsa-miR-93-5p | Medulloblastoma | MNDR-E-MI-71716 |
| MNDR | hsa-miR-93-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-71717 |
| MNDR | hsa-miR-93-5p | Ovarian clear cell carcinoma | MNDR-E-MI-71718 |
| MNDR | hsa-miR-93-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-71719 |
| MNDR | hsa-miR-93-5p | Autism spectrum disorder | MNDR-E-MI-71720 |
| MNDR | hsa-miR-93-5p | Lymphoma | MNDR-E-MI-71721 |
| MNDR | hsa-miR-93-5p | Lymphoma non-hodgkin | MNDR-E-MI-71722 |
| MNDR | hsa-miR-93-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-71723 |
| MNDR | hsa-miR-93-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-71724 |
| MNDR | hsa-miR-93-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-71725 |
| MNDR | hsa-miR-93-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-71726 |
| MNDR | hsa-miR-93-5p | Her2-receptor positive breast cancer | MNDR-E-MI-71727 |
| MNDR | hsa-miR-93-5p | Breast cancer luminal | MNDR-E-MI-71728 |
| MNDR | hsa-miR-93-5p | Muscular disease | MNDR-E-MI-71729 |
| MNDR | hsa-miR-93-5p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-71730 |
| MNDR | hsa-miR-93-5p | B cell acute lymphoblastic leukemia | MNDR-E-MI-71731 |
| MNDR | hsa-miR-93-5p | Autosomal recessive limb-girdle muscular dystrophy type 2a | MNDR-E-MI-71732 |
| MNDR | hsa-miR-93-5p | Autosomal recessive limb-girdle muscular dystrophy type 2b | MNDR-E-MI-71733 |
| MNDR | hsa-miR-93-5p | Prostate cancer | MNDR-E-MI-71734 |
| MNDR | hsa-miR-93-5p | Gastric cancer | MNDR-E-MI-71735 |
| MNDR | hsa-miR-93-5p | Gastric lymphoma | MNDR-E-MI-71736 |
| MNDR | hsa-miR-93-5p | Alzheimer disease | MNDR-E-MI-71737 |
| MNDR | hsa-miR-93-5p | Intracranial aneurysm | MNDR-E-MI-71738 |
| MNDR | hsa-miR-93-5p | Bladder cancer | MNDR-E-MI-71739 |
| MNDR | hsa-miR-93-5p | Esophageal carcinoma | MNDR-E-MI-71740 |
| MNDR | hsa-miR-93-5p | Dysautonomia familial | MNDR-E-MI-71741 |
| MNDR | hsa-miR-93-5p | Polycystic ovary syndrome | MNDR-E-MI-71742 |
| MNDR | hsa-miR-93-5p | Head and neck cancer | MNDR-E-MI-71743 |
| MNDR | hsa-miR-93-5p | Leukemia | MNDR-E-MI-71744 |
| MNDR | hsa-miR-93-5p | Leiomyoma | MNDR-E-MI-71745 |
| MNDR | hsa-miR-93-5p | Huntington disease | MNDR-E-MI-71746 |
| MNDR | hsa-miR-93-5p | Chorea | MNDR-E-MI-71747 |
| MNDR | hsa-miR-93-5p | Cardiovascular disease | MNDR-E-MI-71748 |
| MNDR | hsa-miR-93-5p | Carotid stenosis | MNDR-E-MI-71749 |
| MNDR | hsa-miR-93-5p | Lung cancer | MNDR-E-MI-71750 |
| MNDR | hsa-miR-93-5p | Endometrial cancer | MNDR-E-MI-71751 |
| MNDR | hsa-miR-93-5p | Down syndrome | MNDR-E-MI-71752 |
| MNDR | hsa-miR-93-5p | Fragile x syndrome | MNDR-E-MI-71753 |
| MNDR | hsa-miR-93-5p | Parkinson disease | MNDR-E-MI-71754 |
| MNDR | hsa-miR-93-5p | Basal-like breast cancer | MNDR-E-MI-71755 |
| MNDR | hsa-miR-93-5p | Cancer | MNDR-E-MI-71756 |
| MNDR | hsa-miR-93-5p | Squamous cell carcinoma | MNDR-E-MI-71757 |
| MNDR | hsa-miR-93-5p | Thyroid cancer | MNDR-E-MI-71758 |
| MNDR | hsa-miR-93-5p | Pituitary neoplasms | MNDR-E-MI-71759 |
| MNDR | hsa-miR-93-5p | Pancreatic cancer | MNDR-E-MI-71760 |
| MNDR | hsa-miR-93-5p | Melanoma | MNDR-E-MI-71761 |
| MNDR | hsa-miR-93-5p | Lesch-nyhan syndrome | MNDR-E-MI-71762 |
| MNDR | hsa-miR-93-5p | Nephroblastoma | MNDR-E-MI-71763 |
| MNDR | hsa-miR-93-5p | Colon cancer | MNDR-E-MI-71764 |
| MNDR | hsa-miR-93-5p | Ischemic attack transient | MNDR-E-MI-71765 |
| MNDR | hsa-miR-93-5p | Syndrome | MNDR-E-MI-71766 |
| MNDR | hsa-miR-93-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-71767 |
| MNDR | hsa-miR-93-5p | Familial ovarian cancer | MNDR-E-MI-71768 |
| MNDR | hsa-miR-93-5p | Prostate adenocarcinoma | MNDR-E-MI-71769 |
| MNDR | hsa-miR-93-5p | Laryngeal neoplasms | MNDR-E-MI-71770 |
| MNDR | hsa-miR-93-5p | Kidney cancer | MNDR-E-MI-71771 |
| MNDR | hsa-miR-93-5p | Endometrial carcinoma | MNDR-E-MI-71772 |
| MNDR | hsa-miR-93-5p | Laryngeal squamous cell carcinoma | MNDR-E-MI-71773 |
| MNDR | hsa-miR-93-5p | Pulmonary tuberculosis | MNDR-E-MI-71774 |
| MNDR | hsa-miR-93-5p | Adenocarcinoma | MNDR-E-MI-71775 |
| MNDR | hsa-miR-93-5p | Carcinoma ductal breast | MNDR-E-MI-71776 |
| MNDR | hsa-miR-93-5p | Glioblastoma | MNDR-E-MI-71777 |
| MNDR | hsa-miR-93-5p | Astrocytoma | MNDR-E-MI-71778 |
| MNDR | hsa-miR-93-5p | Glioma | MNDR-E-MI-71779 |
| MNDR | hsa-miR-93-5p | Chronic obstructive pulmonary disease | MNDR-E-MI-71780 |
| MNDR | hsa-miR-93-5p | Nemaline myopathy | MNDR-E-MI-71781 |
| MNDR | hsa-miR-93-5p | Neurilemmoma | MNDR-E-MI-71782 |
| MNDR | hsa-miR-93-5p | Chordoma | MNDR-E-MI-71783 |
| MNDR | hsa-miR-93-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-71784 |
| MNDR | hsa-miR-93-5p | Osteosarcoma | MNDR-E-MI-71785 |
| MNDR | hsa-miR-93-5p | Coronary artery disease | MNDR-E-MI-71786 |
| MNDR | hsa-miR-93-5p | Breast carcinoma | MNDR-E-MI-71787 |
| MNDR | hsa-miR-93-5p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-71788 |
| MNDR | hsa-miR-93-5p | Liver cancer | MNDR-E-MI-71789 |
| MNDR | hsa-miR-93-5p | Uterine cancer | MNDR-E-MI-71790 |
| MNDR | hsa-miR-93-5p | Cervical adenocarcinoma | MNDR-E-MI-71791 |
| MNDR | hsa-miR-93-5p | Gastric adenocarcinoma | MNDR-E-MI-71792 |
| MNDR | hsa-miR-93-5p | Cervical squamous cell carcinoma | MNDR-E-MI-71793 |
| MNDR | hsa-miR-93-5p | Pituitary adenoma | MNDR-E-MI-71794 |
| MNDR | hsa-miR-93-5p | Lung squamous cell carcinoma | MNDR-E-MI-71795 |
| MNDR | hsa-miR-93-5p | Carcinoma lung non-small-cell | MNDR-E-MI-71796 |
| MNDR | hsa-miR-93-5p | Lung adenocarcinoma | MNDR-E-MI-71797 |
| MNDR | hsa-miR-93-5p | Ovarian carcinoma | MNDR-E-MI-71798 |
| MNDR | hsa-miR-93-5p | Bladder urothelial carcinoma | MNDR-E-MI-71799 |
| MNDR | hsa-miR-93-5p | Pancreatic adenocarcinoma | MNDR-E-MI-71800 |
| MNDR | hsa-miR-93-5p | Brain stem cancer | MNDR-E-MI-71801 |
| MNDR | hsa-miR-93-5p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-71802 |
| MNDR | hsa-miR-93-5p | Carcinoma renal cell | MNDR-E-MI-71803 |
| MNDR | hsa-miR-93-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-71804 |
| MNDR | hsa-miR-93-5p | Clear cell renal cell carcinoma | MNDR-E-MI-71805 |
| MNDR | hsa-miR-93-5p | Biliary tract cancer | MNDR-E-MI-71806 |
| MNDR | hsa-miR-93-5p | Esophageal adenocarcinoma | MNDR-E-MI-71807 |
| MNDR | hsa-miR-93-5p | Cholangiocarcinoma | MNDR-E-MI-71808 |
| MNDR | hsa-miR-93-5p | Esophageal cancer | MNDR-E-MI-71809 |
| MNDR | hsa-miR-93-5p | Liver cirrhosis | MNDR-E-MI-71810 |
| MNDR | hsa-miR-93-5p | Prolactinoma | MNDR-E-MI-71811 |
| MNDR | hsa-miR-93-5p | Lung small cell carcinoma | MNDR-E-MI-71812 |
| MNDR | hsa-miR-93-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-71813 |
| MNDR | hsa-miR-93-5p | T acute lymphoblastic leukemia | MNDR-E-MI-71814 |
| MNDR | hsa-miR-93-5p | Acute t cell leukemia | MNDR-E-MI-71815 |
| MNDR | hsa-miR-93-5p | Heart failure | MNDR-E-MI-71816 |
| MNDR | hsa-miR-93-5p | Breast invasive carcinoma | MNDR-E-MI-71817 |
| MNDR | hsa-miR-93-5p | Early hepatocellular carcinoma | MNDR-E-MI-71818 |
| MNDR | hsa-miR-93-5p | Familiar ovarian carcinoma | MNDR-E-MI-71819 |
| MNDR | hsa-miR-93-5p | B-cell lymphoma | MNDR-E-MI-71820 |
| MNDR | hsa-miR-93-5p | Rheumatoid arthritis | MNDR-E-MI-71821 |
| MNDR | hsa-miR-93-5p | T-cell leukemia | MNDR-E-MI-71822 |
| MNDR | hsa-miR-93-5p | Neuroblastoma | MNDR-E-MI-71823 |
| MNDR | hsa-miR-93-5p | Chronic kidney disease | MNDR-E-MI-71824 |
| MNDR | hsa-miR-93-5p | Hodgkin disease | MNDR-E-MI-71825 |
| MNDR | hsa-miR-93-5p | Burkitt lymphoma | MNDR-E-MI-71826 |
| MNDR | hsa-miR-93-5p | Mycosis fungoides | MNDR-E-MI-71827 |
| MNDR | hsa-miR-93-5p | Dementia vascular | MNDR-E-MI-71828 |
| MNDR | hsa-miR-93-5p | Tonsil cancer | MNDR-E-MI-71829 |
| MNDR | hsa-miR-93-5p | Neuromyelitis optica | MNDR-E-MI-71830 |
| MNDR | hsa-miR-93-5p | Degenerative disc disease | MNDR-E-MI-71831 |
| MNDR | hsa-miR-93-5p | Acute myelocytic leukemia | MNDR-E-MI-71832 |
| MNDR | hsa-miR-93-5p | Colorectal cancer | MNDR-E-MI-71833 |
| MNDR | hsa-miR-93-5p | Nasopharynx carcinoma | MNDR-E-MI-71834 |
| MNDR | hsa-miR-93-5p | Multiple myeloma | MNDR-E-MI-71835 |
| MNDR | hsa-miR-93-5p | Acute lymphocytic leukemia | MNDR-E-MI-71836 |
| MNDR | hsa-miR-93-5p | Toxoplasmosis | MNDR-E-MI-71837 |
| MNDR | hsa-miR-93-5p | Brain injuries traumatic | MNDR-E-MI-71838 |
| MNDR | hsa-miR-93-5p | Ovarian epithelial cancer | MNDR-E-MI-71839 |
| MNDR | hsa-miR-93-5p | Ependymoma | MNDR-E-MI-71840 |
| MNDR | hsa-miR-93-5p | Nasopharyngeal cancer | MNDR-E-MI-71841 |
| MNDR | hsa-miR-93-5p | Prostatic neoplasms | MNDR-E-MI-71842 |
| MNDR | hsa-miR-93-5p | Trophoblasts | MNDR-E-MI-71843 |
| MNDR | hsa-miR-93-5p | Vesicular stomatitis | MNDR-E-MI-71844 |
| MNDR | hsa-miR-93-5p | Stroke lacunar | MNDR-E-MI-71845 |
| MNDR | hsa-miR-93-5p | Breast cancer her3+ negative | MNDR-E-MI-71846 |
| MNDR | hsa-miR-93-5p | Duke C | MNDR-E-MI-71847 |
| MNDR | hsa-miR-93-5p | High grade dysplastic nodule | MNDR-E-MI-71848 |
| MNDR | hsa-miR-93-5p | Solid-pseudopapillary neoplasm of pancreas | MNDR-E-MI-71849 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | ABCA1 | Homo sapiens | RR00022148 |
TOP